EXPLORING EFFICIENCY OF LIVING SYSTEMATIC LITERATURE REVIEW (SLR) TOOL FOR SUBMISSIONS OF CLINICAL EVIDENCE TO NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE) BY COMBINING INTERVENTIONAL AND REAL-WORLD EVIDENCE (RWE)

被引：0
|
作者：
Liu, R. [1 ]
Agranat, J. [2 ]
Rizzo, M. [3 ]
Forsythe, A. [4 ]
机构：
[1] Cytel Inc, Toronto, ON, Canada
[2] Cytel Inc, Vaughan, ON, Canada
[3] Cytel, London, England
[4] Cytel, Waltham, MA USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HTA158
引用
收藏
页码：S349 / S349
页数：1
相关论文
共 40 条
  • [31] Retrospective examination of lipid-lowering treatment patterns in a real-world high-risk cohort in the UK in 2014: comparison with the National Institute for Health and Care Excellence (NICE) 2014 lipid modification guidelines
    Steen, Dylan L.
    Khan, Irfan
    Ansell, David
    Sanchez, Robert J.
    Ray, Kausik K.
    BMJ OPEN, 2017, 7 (02):
  • [32] Evidence and Gaps in Clinical Outcomes of L-Glutamine in Sickle Cell Disease: A Systematic Literature Review Highlighting Insights from Clinical Trials and Real-World Studies
    Yassin, Mohamed A.
    BLOOD, 2024, 144 : 5314 - 5315
  • [33] A real-world evidence systematic literature review (slr) of the metrics used to detect veno-occlusive disease/sinusoidal obstruction syndrome (vod/sos) after haematopoietic cell transplantation (hct)
    Angus, J.
    Rutherford, L.
    Moubarak, L.
    Roussi, K.
    Martin, A.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 352 - 353
  • [34] BASAL INSULIN REGIMENS: SYSTEMATIC REVIEW, NETWORK META-ANALYSIS, AND COST - UTILITY ANALYSIS FOR THE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE) CLINICAL GUIDELINE ON TYPE 1 DIABETES MELLITUS IN ADULTS
    Dawoud, D.
    Fenu, E.
    Wonderling, D.
    O'Mahony, R.
    Pursey, N.
    Cobb, J.
    Amiel, S. A.
    Higgins, B.
    VALUE IN HEALTH, 2015, 18 (07) : A339 - A339
  • [35] Effectiveness and safety of dolutegravir two-drug regimens in virologically suppressed people living with HIV: a systematic literature review and meta-analysis of real-world evidence
    Punekar, Y. S.
    Parks, D.
    Joshi, M.
    Kaur, S.
    Evitt, L.
    Chounta, V
    Radford, M.
    Jha, D.
    Ferrante, S.
    Sharma, S.
    Van Wyk, J.
    de Ruiter, A.
    HIV MEDICINE, 2021, 22 (06) : 423 - 433
  • [36] The Value of Large Population-based Electronic Health Record and Insurance Claims Databases for Real-World Evidence Generation in Rare Diseases: a Systematic Literature Review
    Nuvey, Francis Sena
    van Baalen, Valerie
    Didden, Eva-Maria
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 120 - 120
  • [37] Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with -vitamin K antagonists in patients with non-valvular atrial fibrillation: a systematic literature review
    Deitelzweig, Steve
    Lip, Gregory Y. H.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2019, 19 (03) : 243 - 244
  • [38] Effectiveness and tolerability of the two-drug regimen dolutegravir plus lamivudine in people with HIV-1: a systematic literature review of real-world evidence from clinical practice
    Letang, Emilio
    Priest, Julie
    Di Giambenedetto, Simona
    Monforte, Antonella d'Arminio
    Casado, Jose
    Cabello-Ubeda, Alfonso
    Hocqueloux, Laurent
    Allavena, Clotilde
    Barber, Tristan J.
    Jha, Diwakar
    Kamath, Rahul Dinesh
    Sithamparanathan, Myooran
    van Wyk, Jean
    Evitt, Lee
    HIV MEDICINE, 2022, 23 : 37 - 38
  • [39] Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with vitamin K antagonists in patients with nonvalvular atrial fibrillation: a systematic literature review (vol 19, pg 27, 2019)
    Briere, J-B
    Bowrin, K.
    Coleman, C.
    Fauchier, L.
    Levy, P.
    Folkerts, K.
    Toumi, M.
    Taieb, V
    Millier, A.
    Wu, O.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2019, 19 (04) : 503 - 503
  • [40] CYCLIN-DEPENDENT KINASE 4/6 INHIBITORS (CDK4/6I) IN HORMONE RECEPTOR-POSITIVE/HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE (HR+/HER2-) ADVANCED/METASTATIC BREAST CANCER (A/MBC): A SYSTEMATIC LITERATURE REVIEW OF REAL-WORLD EVIDENCE (RWE) STUDIES
    Harbeck, N.
    Bartlett, M.
    Spurden, D.
    Hooper, B.
    Zhan, L.
    Rosta, E.
    Cameron, C.
    Mitra, D.
    Zhou, A.
    VALUE IN HEALTH, 2020, 23 : S27 - S27
1234